Abbott
Price
Price
Historical dividends and forecast
Abbott has so far distributed $2.20 in 2024. The next dividend will be paid on 15.02.2025
CHART BY
Frequently asked questions
What is Abbott's market capitalization?
What is Abbott's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Abbott?
What are the analyst ratings and target price for Abbott's stock?
What is Abbott's revenue over the trailing twelve months?
What is the EBITDA for Abbott?
What is the free cash flow of Abbott?
What is the 5-year beta of Abbott's stock?
How many employees does Abbott have, and what sector and industry does it belong to?
What is the free float of Abbott's shares?
Financials
Market Cap
$201.08B5Y beta
0.72EPS (TTM)
$3.299Free Float
1.73BP/E ratio (TTM)
35.15Revenue (TTM)
$41.22BEBITDA (TTM)
$10.25BFree Cashflow (TTM)
$2.72BPricing
Analyst Ratings
The price target is $125.03 and the stock is covered by 22 analysts.
Buy
16
Hold
6
Sell
0
Information
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
114,000
Medical Equipment & Supplies
Health Care
Identifier
ISIN
Primary Ticker